VRANKEN-POMMERY MONOPOLE - 2016 FULL-YEAR EARNINGS - Net

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
108
VRANKEN-POMMERY MONOPOLE - 2016 FULL-YEAR EARNINGS - Net income up 50% to €6.0 million

  Press release

2016 FULL-YEAR EARNINGS Net income up 50% to €6.0 million

Revenues: €300.1 million Net income: €6.0 million

Reims, 30 th March 2017 - Vranken-Pommery Monopole's Board of Directors met on 30 th March 2017, chaired by Paul-François Vranken and in the presence of the statutory auditors, to approve the Group's financial statements for 2016.

Consolidated accounts In millions of euros 2016 2015 Change (%)
Revenues 300.1 296.6 +1.2%
Operating income (*) % of revenues 21.9 7.3% 22.4 7.6% - 2.2%
Consolidated net income % of revenues 6.0 2.0% 4.0 1.3% +50.0%
Net income, Group share % of revenues 6.0 2.0% 3.8 1.3% +57.9%

 

  (*) After share in net income from associates for the Group's continued operations

Vranken-Pommery Monopole is moving forward with its development strategy · Wine production - In Champagne, the Group has achieved the "Viticulture Durable en Champagne" label - In Camargue and Provence, work to convert over 600 hectares of vineyards to organic production continued in 2016

· Creation of the Sparkling Wines (Traditional Method) division: - In the US, "Louis Pommery California" will start to be distributed in 2017 - In the UK, the Group has set up operations in Hampshire and will also start selling "Louis Pommery England" in 2017 - In France's Camargue region, at the Domaine du Bosquet vineyard which has been restructured to focus on Sparkling Wines, the first harvest will take place in 2017 Commercial commitments have been maintained on international markets, notably making it possible to develop Champagne sales · In Europe, +7% in Germany and +12% in Italy · On other Continents, +25% in Japan and +29% in Australia.

All the components within this strategy made it possible to achieve very good results despite a year marked by: · The continued contraction in business for the restaurant sector in France and Belgium since 2015 · The Pound Sterling's sharp devaluation following the announcement of the Brexit · The significant shortfall with the harvest in the "Sable de Camargue" region  · The deterioration in earnings for Listel SAS

Business analysis

Full-year revenues came to €300.1 million in 2016, compared with €296.6 million for 2015, up 1.2%. Champagne sales to customers totalled €230.8 million in 2016, versus €239.6 million in 2015.

In 2016, the Group consolidated its leading position in France's "Champagne" segment on the mass retail market by ramping up its investments and its presence through operations to strengthen its visibility.

In France and Belgium, Vranken-Pommery Monopole still faces the general decline in the tourism market and the lower number of visitors for both restaurants and hotels. The drop in sales for these sectors accounts for nearly 40% of the overall contraction in Champagne revenues at 31 th December 2016.

In the UK, the Brexit's announcement has led to the Pound Sterling's devaluation and triggered a sharp drop in Champagne shipments. UK distributors have chosen to focus in priority on clearing their stocks. For Vranken-Pommery Monopole, the decline in shipments to the UK represents 60% of the overall contraction in Champagne revenues recorded at 31 th December 2016.                                                                                                                                                                          

Financials

Operating income came to €21.9 million for 2016, compared with €22.4 million in 2015 (-2.2%). To offset the contraction in sales in the UK following the Brexit and for the French and Belgian restaurant sectors following the terrorist attacks, a further €5.8 million of commercial investments have been rolled out for the French mass retail market to further strengthen the Group's leading position in this sector. In addition, the renegotiation of social commitments led to the reversal of €6.2 million of provisions during the year.

Operating income was improved by the reduction in non-current net expenses for €3.8 million and reduced by €1 million for the share in earnings of the associate Listel SAS (industrial restructuring).

Financial income and expenses are stable, with -€17.5 million for 2016, versus -€17.4 million in 2015.

Corporate income tax benefited from the future reduction in tax rates in France and came in positive with €1.8 million at 31 th December 2016.

Factoring in these various elements, net income, Group share, represents €6.0 million for 2016, up from €3.8 million in 2015.

The €651.1 million of net financial debt should be analysed taking into account the deferral of customer payments linked to trade sales over 2017 for €13.5 million.

Shareholders' equity (Group share) is up to €366.3 million from €361.4 million in 2015.

The processes to audit and issue the certification audit report on the consolidated accounts are underway.

Dividends

At the general meeting on 1 st June 2017, Vranken-Pommery Monopole will propose a stable dividend of €0.8 per share.

This dividend will be paid out on 10 th July, with a gross yield of 3.62% based on the share price from 27 th March 2017.

  

Outlook

The investments made by the sales teams internationally in the past few years are expected to pave the way for a return to standard volumes in 2017, with around 18 million bottles of Champagne. In particular, these actions will benefit Pommery & Greno.

In the Champagne business, the creation of the "Brut Nature" (without any added liqueur) is expected to generate interest from new customers focused on purity and the essence of the Champagne region. The "Brut Nature" is one of the key areas for development mapped out by Vranken-Pommery Monopole.

Camargue and Provence rosés, with the Pink Flamingo and Commandeur du Domaine Royal de Jarras vintages, and the Vérité de Terroir and Chapelle Gordonne vintages from Château la Gordonne, have been listed with all the leading French and international retailers. In 2017, Grands Domaines du Littoral is expected to make significant progress with developing the Domaines et Châteaux brands.

Louis Pommery sparkling wines will be released in the US and UK in 2017, while French sparkling wines will drive further progress in this sector across European markets from 2018.

Next date

2017 first-quarter revenues: 27 th April 2017

   About Vranken-Pommery Monopole

Vranken-Pommery Monopole is the second largest Champagne group. With sites in Champagne, Provence, Camargue and Douro, it is Europe's leading wine grower. Its brand portfolio includes:

  • the leading Champagne brands VRANKEN, POMMERY, HEIDSIECK & CO MONOPOLE and CHAMPAGNE CHARLES LAFITTE;
  • the ROZES and SAO PEDRO ports and TERRAS DO GRIFO Douro wine brands;
  • the Sable de Camargue DOMAINE ROYAL DE JARRAS rosé wines and Côtes de Provence CHATEAU LA GORDONNE.

In addition, it is the joint owner, with the Castel Group, of the LISTEL brand portfolio.

Vranken-Pommery Monopole is listed on NYSE Euronext (Paris and Brussels). (Codes "VRAP" (Paris), and "VRAB" (Brussels); ISIN: FR0000062796).

Contacts

Vranken-Pommery Monopole: Patrice Proth, General Secretary +33 3 26 61 62 34, comfi@vrankenpommery.fr Press Claire Doligez, +33 1 53 70 74 25, cdoligez@image7.fr Caroline Simon, +33 1 53 70 74 65, caroline.simon@image7.fr
Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...6a96268e10

Scroll down for more posts ▼

Top 10 Most Recent News Articles

DraftKings Faces Revenue Cutback; Legal Probe Begins

Updated Category News Views 103

DraftKings' Surprising Turn of Fortune Talk about a gut punch! DraftKings (NASDAQ: DKNG) dropped a bombshell that had investors reeling. They decided to lop off a hefty slice of their revenue guidance, and trust me, those aren't small numbers we’re talking about. On November 6, they yanked their full-year 2026 revenue guidance down to $6.35 billion to $6.55 billion from...

Continue Reading
Andersen's Window Revamp: Addressing Demand Surge

Updated Category News Views 96

Portfolio Boost: Adapting to Market Needs If you're sniffing around the windows business, there's a fresh breeze of innovation blowing from Andersen. They're not just sitting around drumming their fingers—they're rolling up their sleeves and fine-tuning their offerings. With half of homeowners swinging a hammer on renovations last year, the company sees an opportunity...

Continue Reading
Tenax Therapeutics Faces Legal Heat After Stock Plunge

Updated Category News Views 92

Investors' Nerves Tested as Tenax Takes a Nosedive Holy smokes! When a biotech company like Tenax Therapeutics, Inc. (NASDAQ: TENX) detonates like a forgotten fireworks stash, investors have every right to get itchy. Tenax’s shocking announcement that their Phase 3 LEVEL trial for TNX-103 flopped has sparked more than just shareholder anxiety. It’s ignited a...

Continue Reading
212NYC Gala Celebrates Ad Industry's Human Touch

Updated Category News Views 157

The Advertising Gala with Heart When you toss nearly 300 advertising honchos into a room at Tribeca's Rooftop, you don't just get another bash; you get an industry checkpoint. This time, the 212NYC shindig on November 5, 2026, wasn't just about stroking egos. It was about spotlighting the soul in business, right when AI threatens to run wild with it. Navigating AI's...

Continue Reading
Pete Crow-Armstrong Unveils Signature Baseball Gloves

Updated Category News Views 83

The Windy City Meets the Diamond Alright, bear with me here. Monday morning vibes, right? But here's something that'll turn your breakfast around if you're into baseball—or just the latest scoop on players making waves in gear. Pete Crow-Armstrong, the Chicago Cubs center fielder who's been lighting up the field, has his name on some fresh gear. We're talking signature...

Continue Reading
PAC Criticizes JD Vance's Billionaire Connections

Updated Category News Views 107

Unveiling Vance's High-Powered Backers Brace yourself for a fresh round of political sparring, folks. The Patriots for American Principles PAC has decided that JD Vance's relationships with the billionaire elite need a little more sunshine. And they're not shy about it—Vance's billionaires will be paraded around the streets of Washington D.C. on a mobile billboard,...

Continue Reading
Koppers Navigates Q3: Margins Squeeze Amid Growth

Updated Category News Views 123

Investing in Koppers: A Mixed Bag in Q3 Well, it appears Koppers (NYSE: KOP) is doing a bit of a dance this quarter—some smooth steps, but a few stumbles in the rhythm when it comes to margins. The hardwood numbers tell an interesting tale, so let's break it down. Sales Edge Up, But Margins Suffer Koppers clocked in net sales of $499.1 million for the third quarter of...

Continue Reading
Precision Biologics Unveils Promising Data on PB-223

Updated Category News Views 95

Precision's Big Reveal at SITC 2026 When it comes to the shifting tides of oncology advancements, Precision Biologics is making some serious waves. They're not leaning back; they're diving right in with their latest showcase at the Society for Immunotherapy of Cancer (SITC) Annual Meeting, 2026. CEO Dr. Philip M. Arlen announced compelling preclinical data for their...

Continue Reading
Everest Group Faces Class Action: Key Investor Moves

Updated Category News Views 117

Everest Group's Legal Spiral: What's Happening? Folks, when a company feels like it's caught in an endless storm, investors better hold on tight. That's the situation Everest Group, Ltd. finds itself in, with an 11.4% stock dive that’s got investors reeling. Securities fraud allegations are rocking Everest like a hurricane, and The Law Offices of Frank R. Cruz have put...

Continue Reading
OncoC4's Cesalatamig: Promising Results in NSCLC Trials

Updated Category News Views 85

Hope in Persistence: Cesalatamig in the Spotlight Swinging through the medical landscape like a seasoned fighter, OncoC4's recent revelations at the SITC 2026 give investors and doctors a reason to pay close attention. We're sizing up their investigational drug, cesalatamig, which flaunts a solid objective response rate of 33% among non-small cell lung cancer (NSCLC)...

Continue Reading

Top 5 Most Recently Viewed Articles

Shipley Donuts Expands to Vienna, Delight in Every Bite

Updated Category News Views 73

Shipley Donuts: A Sweet Texas Tradition Lands in Virginia The donut world just got a little tastier in Northern Virginia as Shipley Donuts, that iconic Texan sweetheart, opened shop in Vienna. We're talking handmade donuts, done the old-school way, with a taste that makes you wanna grab a dozen before work. They’ve been crafting this magic for nearly a century, starting...

Continue Reading
Volato's Strategic Expansion with Gulfstream G280 Deliveries

Updated Category News Views 224

Volato's Exciting Addition to Its Fleet Volato Group, Inc. (the "Company" or "Volato") (NYSE American: SOAR), a frontrunner in private aviation, is thrilled to announce a significant milestone: the delivery of its second Gulfstream G280 is set for January 2025. This delivery is part of a strategic order of four aircraft and underscores the company’s proactive approach...

Continue Reading
Velico's Partnership with South Texas Blood Center Revolutionizes Plasma Access

Updated Category News Views 355

Transforming Plasma Access with Innovative Technology In a historic move, the South Texas Blood and Tissue Center (STBT) has become the first civilian blood center in the U.S. to adopt Velico, Inc.'s revolutionary FrontlineODP™ system. This groundbreaking partnership aims to enhance emergency medical practices by providing on-demand spray-dried plasma, making...

Continue Reading
The Incredible Growth of Teradyne: A Decade of Investment

Updated Category News Views 119

Investing in Teradyne: A Decade of Incredible Returns When it comes to long-term investments, certain stocks have consistently proven their worth. Teradyne (NASDAQ: TER) is one such company that has outperformed market expectations over the past decade. With an impressive annualized performance exceeding 11.62%, Teradyne has become a staple in many investors' portfolios....

Continue Reading
Grid Battery Metals Expands Copper Portfolio for Future Growth

Updated Category News Views 126

Grid Battery Metals' Exciting New Copper Acquisition Grid Battery Metals Inc. has made a significant move by acquiring a new copper project, broadening its portfolio in the battery metals sector. Tim Fernback, the President and CEO, articulated the strategic importance of this acquisition and its implications for future exploration activities. Strategic Location of the...

Continue Reading